GO:0006259 | DNA metabolic process | 13.93% (17/122) | 3.91 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 11.48% (14/122) | 3.4 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 4.1% (5/122) | 6.98 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 13.93% (17/122) | 2.9 | 0.0 | 0.0 |
GO:0005634 | nucleus | 6.56% (8/122) | 4.55 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.75% (18/122) | 2.46 | 0.0 | 0.0 |
GO:0043226 | organelle | 9.02% (11/122) | 3.51 | 0.0 | 0.0 |
GO:0005488 | binding | 33.61% (41/122) | 1.36 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 9.02% (11/122) | 3.53 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 14.75% (18/122) | 2.36 | 0.0 | 0.0 |
GO:0043231 | intracellular membrane-bounded organelle | 6.56% (8/122) | 4.14 | 0.0 | 0.0 |
GO:0043227 | membrane-bounded organelle | 6.56% (8/122) | 4.14 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 14.75% (18/122) | 2.37 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 15.57% (19/122) | 2.25 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 14.75% (18/122) | 2.34 | 0.0 | 0.0 |
GO:0006260 | DNA replication | 4.92% (6/122) | 4.92 | 0.0 | 1e-06 |
GO:0034641 | cellular nitrogen compound metabolic process | 14.75% (18/122) | 2.18 | 0.0 | 1e-06 |
GO:0003676 | nucleic acid binding | 13.11% (16/122) | 2.29 | 0.0 | 2e-06 |
GO:0097159 | organic cyclic compound binding | 20.49% (25/122) | 1.66 | 0.0 | 3e-06 |
GO:1901363 | heterocyclic compound binding | 20.49% (25/122) | 1.66 | 0.0 | 3e-06 |
GO:0043170 | macromolecule metabolic process | 15.57% (19/122) | 1.71 | 5e-06 | 5.9e-05 |
GO:0009059 | macromolecule biosynthetic process | 6.56% (8/122) | 3.02 | 7e-06 | 7.7e-05 |
GO:0036094 | small molecule binding | 13.93% (17/122) | 1.75 | 1.1e-05 | 0.000125 |
GO:0044424 | intracellular part | 9.84% (12/122) | 2.19 | 1.4e-05 | 0.000145 |
GO:0005524 | ATP binding | 11.48% (14/122) | 1.92 | 2e-05 | 0.000192 |
GO:0003674 | molecular_function | 37.7% (46/122) | 0.84 | 2e-05 | 0.000198 |
GO:0030554 | adenyl nucleotide binding | 11.48% (14/122) | 1.91 | 2.2e-05 | 0.0002 |
GO:0032559 | adenyl ribonucleotide binding | 11.48% (14/122) | 1.91 | 2.2e-05 | 0.000202 |
GO:0000166 | nucleotide binding | 13.11% (16/122) | 1.73 | 2.6e-05 | 0.000208 |
GO:1901265 | nucleoside phosphate binding | 13.11% (16/122) | 1.73 | 2.6e-05 | 0.000208 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.64% (2/122) | 7.66 | 2.4e-05 | 0.000209 |
GO:0044237 | cellular metabolic process | 16.39% (20/122) | 1.48 | 2.8e-05 | 0.000223 |
GO:0044464 | cell part | 9.84% (12/122) | 2.07 | 3e-05 | 0.000225 |
GO:0008144 | drug binding | 11.48% (14/122) | 1.85 | 3.4e-05 | 0.000253 |
GO:0006807 | nitrogen compound metabolic process | 16.39% (20/122) | 1.46 | 3.6e-05 | 0.000257 |
GO:0016779 | nucleotidyltransferase activity | 4.1% (5/122) | 3.72 | 4e-05 | 0.000273 |
GO:0097367 | carbohydrate derivative binding | 12.3% (15/122) | 1.75 | 4e-05 | 0.000278 |
GO:0003896 | DNA primase activity | 1.64% (2/122) | 7.08 | 7.2e-05 | 0.000478 |
GO:0043168 | anion binding | 12.3% (15/122) | 1.64 | 9.7e-05 | 0.000622 |
GO:0009987 | cellular process | 18.85% (23/122) | 1.23 | 0.000101 | 0.000633 |
GO:0035639 | purine ribonucleoside triphosphate binding | 11.48% (14/122) | 1.7 | 0.000109 | 0.000667 |
GO:0044238 | primary metabolic process | 16.39% (20/122) | 1.34 | 0.000113 | 0.000676 |
GO:0032555 | purine ribonucleotide binding | 11.48% (14/122) | 1.69 | 0.000117 | 0.000683 |
GO:0017076 | purine nucleotide binding | 11.48% (14/122) | 1.68 | 0.000124 | 0.000709 |
GO:0032553 | ribonucleotide binding | 11.48% (14/122) | 1.66 | 0.000146 | 0.000781 |
GO:0051052 | regulation of DNA metabolic process | 1.64% (2/122) | 6.66 | 0.000144 | 0.000787 |
GO:0006275 | regulation of DNA replication | 1.64% (2/122) | 6.66 | 0.000144 | 0.000787 |
GO:0071704 | organic substance metabolic process | 16.39% (20/122) | 1.28 | 0.000197 | 0.001031 |
GO:0034645 | cellular macromolecule biosynthetic process | 4.92% (6/122) | 2.83 | 0.00021 | 0.001054 |
GO:0140097 | catalytic activity, acting on DNA | 3.28% (4/122) | 3.78 | 0.000209 | 0.00107 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.46% (3/122) | 4.49 | 0.000315 | 0.001552 |
GO:0034061 | DNA polymerase activity | 2.46% (3/122) | 4.44 | 0.000352 | 0.001698 |
GO:0043167 | ion binding | 13.93% (17/122) | 1.33 | 0.000395 | 0.001869 |
GO:0005515 | protein binding | 13.11% (16/122) | 1.29 | 0.000798 | 0.003708 |
GO:0044249 | cellular biosynthetic process | 7.38% (9/122) | 1.87 | 0.000859 | 0.003919 |
GO:1901576 | organic substance biosynthetic process | 7.38% (9/122) | 1.83 | 0.001014 | 0.004544 |
GO:0006281 | DNA repair | 3.28% (4/122) | 3.12 | 0.001178 | 0.005188 |
GO:0033554 | cellular response to stress | 3.28% (4/122) | 3.06 | 0.001377 | 0.005761 |
GO:0051716 | cellular response to stimulus | 3.28% (4/122) | 3.06 | 0.001377 | 0.005761 |
GO:0006974 | cellular response to DNA damage stimulus | 3.28% (4/122) | 3.06 | 0.001377 | 0.005761 |
GO:0009058 | biosynthetic process | 7.38% (9/122) | 1.72 | 0.001723 | 0.007091 |
GO:0006950 | response to stress | 3.28% (4/122) | 2.93 | 0.001909 | 0.007726 |
GO:0005694 | chromosome | 1.64% (2/122) | 4.75 | 0.002436 | 0.009704 |
GO:0008152 | metabolic process | 16.39% (20/122) | 0.96 | 0.002882 | 0.011301 |
GO:0050896 | response to stimulus | 3.28% (4/122) | 2.75 | 0.002994 | 0.01156 |
GO:0000776 | kinetochore | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0031262 | Ndc80 complex | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0051097 | negative regulation of helicase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0051095 | regulation of helicase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0034629 | cellular protein-containing complex localization | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0031144 | proteasome localization | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0071630 | nuclear protein quality control by the ubiquitin-proteasome system | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0050797 | thymidylate synthase (FAD) activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0042555 | MCM complex | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0019692 | deoxyribose phosphate metabolic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0006231 | dTMP biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0046073 | dTMP metabolic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0046385 | deoxyribose phosphate biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:1905463 | negative regulation of DNA duplex unwinding | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:1905774 | regulation of DNA helicase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:1905775 | negative regulation of DNA helicase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0019206 | nucleoside kinase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:1905462 | regulation of DNA duplex unwinding | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0019136 | deoxynucleoside kinase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0004797 | thymidine kinase activity | 0.82% (1/122) | 7.66 | 0.004939 | 0.012274 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.64% (2/122) | 3.91 | 0.007833 | 0.019276 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 0.82% (1/122) | 6.66 | 0.009854 | 0.022484 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.82% (1/122) | 6.66 | 0.009854 | 0.022484 |
GO:0010498 | proteasomal protein catabolic process | 0.82% (1/122) | 6.66 | 0.009854 | 0.022484 |
GO:0031503 | protein-containing complex localization | 0.82% (1/122) | 6.66 | 0.009854 | 0.022484 |
GO:0006333 | chromatin assembly or disassembly | 0.82% (1/122) | 6.66 | 0.009854 | 0.022484 |
GO:2001251 | negative regulation of chromosome organization | 0.82% (1/122) | 6.66 | 0.009854 | 0.022484 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.64% (2/122) | 3.75 | 0.009615 | 0.023205 |
GO:0097747 | RNA polymerase activity | 1.64% (2/122) | 3.75 | 0.009615 | 0.023205 |
GO:0005575 | cellular_component | 9.84% (12/122) | 1.09 | 0.010813 | 0.024451 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 5.74% (7/122) | 1.5 | 0.012188 | 0.027313 |
GO:0008150 | biological_process | 20.49% (25/122) | 0.66 | 0.013441 | 0.029855 |
GO:0006220 | pyrimidine nucleotide metabolic process | 0.82% (1/122) | 6.08 | 0.014744 | 0.030088 |
GO:0043086 | negative regulation of catalytic activity | 0.82% (1/122) | 6.08 | 0.014744 | 0.030088 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 0.82% (1/122) | 6.08 | 0.014744 | 0.030088 |
GO:0044092 | negative regulation of molecular function | 0.82% (1/122) | 6.08 | 0.014744 | 0.030088 |
GO:0051346 | negative regulation of hydrolase activity | 0.82% (1/122) | 6.08 | 0.014744 | 0.030088 |
GO:0019205 | nucleobase-containing compound kinase activity | 0.82% (1/122) | 6.08 | 0.014744 | 0.030088 |
GO:0005815 | microtubule organizing center | 0.82% (1/122) | 6.08 | 0.014744 | 0.030088 |
GO:0043232 | intracellular non-membrane-bounded organelle | 2.46% (3/122) | 2.59 | 0.013789 | 0.030096 |
GO:0043228 | non-membrane-bounded organelle | 2.46% (3/122) | 2.59 | 0.013789 | 0.030096 |
GO:0006310 | DNA recombination | 1.64% (2/122) | 3.45 | 0.014394 | 0.031145 |
GO:0030163 | protein catabolic process | 0.82% (1/122) | 5.66 | 0.019611 | 0.038455 |
GO:0051336 | regulation of hydrolase activity | 0.82% (1/122) | 5.66 | 0.019611 | 0.038455 |
GO:0043015 | gamma-tubulin binding | 0.82% (1/122) | 5.66 | 0.019611 | 0.038455 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 0.82% (1/122) | 5.66 | 0.019611 | 0.038455 |
GO:0033044 | regulation of chromosome organization | 0.82% (1/122) | 5.66 | 0.019611 | 0.038455 |
GO:0003910 | DNA ligase (ATP) activity | 0.82% (1/122) | 5.34 | 0.024454 | 0.046854 |
GO:0051129 | negative regulation of cellular component organization | 0.82% (1/122) | 5.34 | 0.024454 | 0.046854 |
GO:0010639 | negative regulation of organelle organization | 0.82% (1/122) | 5.34 | 0.024454 | 0.046854 |